Glass Lewis Recommends Voting AGAINST Aska Pharmaceutical Holdings’ Proposal No. 11 June 15, 2026 Dalton Investments welcomes the recommendation by Glass Lewis & Co. (“Glass Lewis”), the independent proxy advisory firm, that shareholders vote AGAINST Proposal No. 11 at the . . .
Glass Lewis Recommends Voting AGAINST Aska Pharmaceutical Holdings’ Proposal No. 11
Posted June 15, 2026